Three of the most heavily invested players in the pharmaceutical industry are at odds. Pharmaceutical manufacturers have to recoup R&D costs and demonstrate accountability to their leadership and shareholders. PBMs are responsible for driving down costs for their plan sponsors. Frequently, this is achieved by hard negotiations with manufacturers. Pharmacists, the healthcare providers best positioned […]